Solar simplified
Alpha Ventus wind turbines in the North Sea
Offshore turbine - 3D presentation
MISTRAL 20-600 kVA Fuel cell Backup power system
Gilles, Civil Engineering Referent
Jean-Christophe, Mechanical Calculation Engineer
Emmanuelle, Solar R&D Program Manager
Report on diversity 2010
Tomorrow’s challenges mobilizing all talent
Field Report: Discover pragmatic examples of customer benefits
Fighting disease with 212-Pb
212Pb is a rare isotope found in certain by-products of AREVA processes.
Over the past few years, AREVA Med and its partners have demonstrated the benefits of using 212Pb in alpha radioimmunotherapy. This treatment shows great potential for combating fatal diseases including pancreatic, ovarian, colon, breast and prostate cancer.
What is 212-Pb?
Part of the thorium-228 decay chain, this radioisotope lies at the heart of promising research to develop new cancer treatments.
Understanding radioimmunotherapy
Alpha radioimmunotherapy is a targeted treatment with great potential for ovarian, prostate, breast and other cancers.
Groundbreaking research
AREVA Med conducts cutting-edge radiochemistry research at the group’s Bessines facility in France.
